Cord Blood Stem Cell Transplantation
"Cord Blood Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation of STEM CELLS collected from the fetal blood remaining in the UMBILICAL CORD and the PLACENTA after delivery. Included are the HEMATOPOIETIC STEM CELLS.
| Descriptor ID |
D036101
|
| MeSH Number(s) |
E02.095.147.500.500.312 E04.936.225.687.312
|
| Concept/Terms |
Cord Blood Stem Cell Transplantation- Cord Blood Stem Cell Transplantation
- Stem Cell Transplantation, Placental Blood
- Umbilical Cord Blood Stem Cell Transplantation
- Placental Blood Stem Cell Transplantation
- Stem Cell Transplantation, Cord Blood
- Blood Stem Cell Transplantation, Umbilical Cord
|
Below are MeSH descriptors whose meaning is more general than "Cord Blood Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Cord Blood Stem Cell Transplantation".
This graph shows the total number of publications written about "Cord Blood Stem Cell Transplantation" by people in this website by year, and whether "Cord Blood Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 1 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 3 | 1 | 4 |
| 2012 | 3 | 0 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 4 | 1 | 5 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 2 | 0 | 2 |
| 2023 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cord Blood Stem Cell Transplantation" by people in Profiles.
-
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival. Blood Adv. 2023 05 09; 7(9):1823-1830.
-
Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy. Transplant Cell Ther. 2023 06; 29(6):347.e1-347.e11.
-
Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future. Stem Cells Transl Med. 2023 03 03; 12(2):55-71.
-
Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation. Cell Transplant. 2023 Jan-Dec; 32:9636897231194497.
-
Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil. Ann Hematol. 2022 Dec; 101(12):2743-2757.
-
Single Cord Blood Transplantation Versus HLA-Haploidentical-related Donor Transplantation Using Posttransplant Cyclophosphamide in Patients With Hematological Malignancies. Transplantation. 2022 06 01; 106(6):1279-1287.
-
Guidelines for Pediatric Unrelated Cord Blood Transplantation-Unique Considerations. Transplant Cell Ther. 2021 12; 27(12):968-972.
-
Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation. Int J Hematol. 2021 Jul; 114(1):129-135.
-
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin. Ann Hematol. 2021 Mar; 100(3):743-752.
-
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation. Blood Adv. 2019 12 10; 3(23):4117-4130.